Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences.
Randall J. Olsen,Randall J. Olsen,Paul A. Christensen,S. Wesley Long,S. Wesley Long,Sishir Subedi,Parsa Hodjat,Robert Olson,Robert Olson,Marcus Nguyen,Marcus Nguyen,James J. Davis,James J. Davis,Prasanti Yerramilli,Matthew Ojeda Saavedra,Layne Pruitt,Kristina Reppond,Madison N. Shyer,Jessica Cambric,Ryan Gadd,Rashi M. Thakur,Akanksha Batajoo,Ilya J. Finkelstein,Jimmy Gollihar,Jimmy Gollihar,James M. Musser,James M. Musser +26 more
Reads0
Chats0
TLDR
In this article, the trajectory of SARS-CoV2 variants circulating in a major metropolitan area, documents B.1.7 as the major cause of new cases in Houston, TX, and heralds the arrival of B.617 variants in the metroplex.Abstract:
Certain genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of substantial concern because they may be more transmissible or detrimentally alter the pandemic course and disease features in individual patients. SARS-CoV-2 genome sequences from 12,476 patients in the Houston Methodist health care system diagnosed from January 1 through May 31, 2021 are reported here. Prevalence of the B.1.1.7 (Alpha) variant increased rapidly and caused 63% to 90% of new cases in the latter half of May. Eleven B.1.1.7 genomes had an E484K replacement in spike protein, a change also identified in other SARS-CoV-2 lineages. Compared with non-B.1.1.7-infected patients, individuals with B.1.1.7 had a significantly lower cycle threshold (a proxy for higher virus load) and significantly higher hospitalization rate. Other variants [eg, B.1.429 and B.1.427 (Epsilon), P.1 (Gamma), P.2 (Zeta), and R.1] also increased rapidly, although the magnitude was less than that in B.1.1.7. Twenty-two patients infected with B.1.617.1 (Kappa) or B.1.617.2 (Delta) variants had a high rate of hospitalization. Breakthrough cases (n = 207) in fully vaccinated patients were caused by a heterogeneous array of virus genotypes, including many not currently designated variants of interest or concern. In the aggregate, this study delineates the trajectory of SARS-CoV-2 variants circulating in a major metropolitan area, documents B.1.1.7 as the major cause of new cases in Houston, TX, and heralds the arrival of B.1.617 variants in the metroplex.read more
Citations
More filters
Journal ArticleDOI
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Paul A. Christensen,Randall J. Olsen,S. Wesley Long,R. D. Snehal,James J. Davis,Matthew Ojeda Saavedra,K. Reppond,Madison N. Shyer,Jessica E. Cambric,Ryan D. H. Gadd,R. M. Thakur,A. Batajoo,R. Mangham,S Silva Peña,Tri Quang Trinh,Jacob C. Kinskey,Guy Williams,Robert Olson,Jimmy Gollihar,James M. Musser +19 more
TL;DR: In this article , a genome sequencing study of SARS-CoV-2 in the Houston Methodist health care system identified 4468 symptomatic patients with infections caused by Omicron (B.1.529) from late November 2021 through January 5, 2022.
Journal ArticleDOI
Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer
Suresh V. Kuchipudi,Meera Surendran-Nair,Rachel Ruden,Michèle Gan Yon,Ruth H. Nissly,Kurt J. Vandegrift,Rahul K. Nelli,Lingling Li,Bhushan M. Jayarao,Costas D. Maranas,Nicole Levine,Katriina Willgert,Andrew J. K. Conlan,Randall J. Olsen,James J. Davis,James M. Musser,Peter J. Hudson,Vivek Kapur +17 more
TL;DR: The discovery of widespread infection of white-tailed deer indicates their establishment as potential reservoir hosts for SARS-CoV-2, a finding with important implications for the ecology, long-term persistence, and evolution of the virus, including the potential for spillback to humans.
Journal ArticleDOI
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas.
Paul A. Christensen,Randall J. Olsen,S. Wesley Long,Sishir Subedi,James J. Davis,Parsa Hodjat,Debbie R. Walley,Jacob C. Kinskey,Matthew Ojeda Saavedra,Layne Pruitt,Kristina Reppond,Madison N. Shyer,Jessica Cambric,Ryan Gadd,Rashi M. Thakur,Akanksha Batajoo,Regan Mangham,Sindy Pena,Trina Trinh,Prasanti Yerramilli,Marcus Nguyen,Robert Olson,Richard Snehal,Jimmy Gollihar,James M. Musser +24 more
TL;DR: In this paper, the authors sequenced the genomes of 16,965 SARS-CoV-2 from samples acquired March 15, 2021 through September 20, 2021 in the Houston Methodist hospital system.
Journal ArticleDOI
Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
TL;DR: The integrated analysis indicates that vaccines used in the United States are highly effective in decreasing severe acute respiratory syndrome coronavirus disease 2019 (COVID-19) pandemic, hospitalizations, and deaths as mentioned in this paper .
Journal ArticleDOI
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
TL;DR: In 2019, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) separately developed a categorization system for differentiating new strains of SARS-CoV-2 into variants of concern and variants of interest as mentioned in this paper .
References
More filters
Journal ArticleDOI
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
Carolina M. Voloch,Ronaldo da Silva Francisco,Luiz Gonzaga Paula de Almeida,Cynthia Chester Cardoso,Otávio J. B. Brustolini,Alexandra L. Gerber,Ana Paula de C Guimarães,Diana Mariani,Raissa Mirella da Costa,Orlando C. Ferreira,Thiago Silva Frauches,Claudia Maria Braga de Mello,Isabela de Carvalho Leitão,Rafael Mello Galliez,Débora S. Faffe,Terezinha M. P. P. Castineiras,Amilcar Tanuri,Ana Tereza Ribeiro de Vasconcelos +17 more
TL;DR: In this article, the emergence of novel SARS-CoV-2 lineages characterized by their phylogenetic and genetic distinction was reported, and several studies reported that these lineages can be classified into two groups.
Journal ArticleDOI
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.
Sophie M. C. Gobeil,Katarzyna Janowska,Shana McDowell,Katayoun Mansouri,Robert Parks,Victoria Stalls,Megan Kopp,Kartik Manne,Dapeng Li,Kevin Wiehe,Kevin Wiehe,Kevin O. Saunders,Robert J. Edwards,Robert J. Edwards,Bette T. Korber,Barton F. Haynes,Barton F. Haynes,Rory Henderson,Rory Henderson,Priyamvada Acharya,Priyamvada Acharya +20 more
TL;DR: In this article, the authors combined cryo-electron microscopy (cryo-EM), binding, and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations.
Journal ArticleDOI
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.
Waleed Nasser,Stephen B. Beres,Randall J. Olsen,Melissa A. Dean,Kelsey A. Rice,S. Wesley Long,Karl G. Kristinsson,Magnus Gottfredsson,Jaana Vuopio,Kati Räisänen,Dominique A. Caugant,Martin Steinbakk,Donald E. Low,Allison McGeer,Jessica Darenberg,Birgitta Henriques-Normark,Birgitta Henriques-Normark,Chris A. Van Beneden,Steen Hoffmann,James M. Musser +19 more
TL;DR: Analysis of 3,615 genome sequences permitted us to delineate the nature and timing of molecular events that contributed to an ongoing global human epidemic of infections caused by group A Streptococcus, the “flesh-eating” pathogen, and resolve a decades-long controversy about the type and sequence of genomic alterations that produced this explosive epidemic.
Journal ArticleDOI
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
Nicole L. Washington,Karthik Gangavarapu,Mark Zeller,Alexandre Bolze,Elizabeth T. Cirulli,Kelly M. Schiabor Barrett,Brendan B. Larsen,Catelyn Anderson,Simon R. White,Tyler Cassens,Sharoni Jacobs,Geraint Levan,Jason Nguyen,Jimmy M. Ramirez,Charlotte Rivera-Garcia,Efren Sandoval,Xueqing Wang,David T.W. Wong,Emily Spencer,Refugio Robles-Sikisaka,Ezra Kurzban,Laura D. Hughes,Xianding Deng,Candace Wang,Venice Servellita,Holly Valentine,Peter De Hoff,Phoebe Seaver,Shashank Sathe,Kimberly Gietzen,Brad Sickler,Jay Antico,Kelly Hoon,Jingtao Liu,Aaron Harding,Omid Bakhtar,Tracy Basler,Brett Austin,Duncan MacCannell,Magnus Isaksson,Phillip G. Febbo,David M. Becker,Marc Laurent,Eric McDonald,Gene W. Yeo,Rob Knight,Louise C. Laurent,Eileen de Feo,Michael Worobey,Charles Y. Chiu,Marc A. Suchard,James T. Lu,William E. Lee,Kristian G. Andersen +53 more
TL;DR: In this paper, the authors investigated the prevalence and dynamics of B.1.7 in the United States (US), tracking it back to its early emergence using S gene target failure (SGTF) and SARS-CoV-2 genomic sequencing.
Posted ContentDOI
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
Sarah S. Cherian,Varsha Potdar,Santosh Jadhav,Pragya D Yadav,Nivedita Gupta,Mousmi Das,Partha Rakshit,Sujeet Kumar Singh,Priya Abraham,Samiran Panda,Nic team +10 more
TL;DR: In this paper, a whole genome sequencing and analysis of spike protein mutations using sequence and structural approaches was undertaken to identify possible new variants and gauge the fitness of current circulating strains of SARS-CoV-2.
Related Papers (5)
Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021.
Kenneth A. Feder,Marcia Pearlowitz,Alexandra Goode,Monique Duwell,Thelonious W. Williams,Ping An Chen-Carrington,Ami Patel,Catherine Dominguez,Eric N. Keller,Liore Klein,Alessandra Rivera-Colon,Heba H. Mostafa,C. Paul Morris,Neil Patel,Anna M. Schauer,Robert Myers,David Blythe,Katherine A. Feldman +17 more